Condition: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I · Sponsor: Peking University People's Hospital
To explore the treatment efficacy of Progesterone Therapeutic Regimen Plus Statins in patients with atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EEC) for conservative treatment.
This description comes directly from the study's public registry record.
Jianliu Wang, professor · 00861088324381 · wangjianliu1203@163.com
HE YIJIAO, PHD/MD · 18301512017 · heyijiao2017@pku.edu.cn
Always discuss trial participation with your own doctor first.
| Peking University People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06102863